Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is dysgerminoma?
Dysgerminoma is a type of ovarian cancer that grows from the egg-producing 'germ' cells of the ovary. It is the most common malignant germ-cell tumor of the ovary and tends to appear in girls and women in their teens and twenties. It is the ovarian counterpart of a testicular seminoma, and like that tumor it is remarkably sensitive to both chemotherapy and radiation. Most dysgerminomas are found while still confined to one ovary, often as a fast-growing but still-curable mass. Even when the disease has spread, the outlook is excellent because the tumor responds so well to treatment. Because patients are usually young, doctors work hard to cure the cancer while protecting fertility, and they follow blood markers such as LDH (and sometimes beta-hCG) to track the tumor. A small share occur in people with certain underlying genetic conditions affecting the gonads, which is why karyotype testing is sometimes recommended.
The main types
Doctors group dysgerminoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Pure dysgerminoma | Made up only of dysgerminoma cells. This is the classic form and the most treatable, with outstanding cure rates. |
| Mixed germ-cell tumor with a dysgerminoma component | Dysgerminoma combined with other germ-cell types (such as yolk-sac tumor or teratoma). The other components can change marker levels and the chemotherapy plan. |
Staging, in plain terms
Dysgerminoma uses the same FIGO stages as other ovarian cancers to describe how far it has spread. Unlike most cancers, even higher-stage dysgerminoma is usually curable because it responds so well to chemotherapy, so stage guides how much treatment is needed rather than whether cure is possible.
| Ovarian cancer FIGO staging | What it generally means |
|---|---|
| Stage I | Confined to one or both ovaries. The most common situation; often cured with fertility-sparing surgery alone, sometimes with careful observation afterward. |
| Stage II | Spread to other structures within the pelvis. Treated with surgery plus chemotherapy, still with excellent cure rates. |
| Stage III | Spread to the lining of the abdomen or to lymph nodes. Highly curable with surgery and chemotherapy. |
| Stage IV | Spread to distant organs such as the lungs or liver. Even here, combined chemotherapy cures the large majority of patients. |
The standard of care
Dysgerminoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Fertility-sparing surgery
For most young women, surgeons remove only the affected ovary and fallopian tube, leaving the uterus and other ovary in place so childbearing remains possible. Staging is done at the same time.
Chemotherapy (BEP)
A platinum-based combination — usually bleomycin, etoposide, and cisplatin (BEP) — is the workhorse for tumors that have spread or have higher-risk features, and it cures the great majority of patients.
Surveillance for early disease
For a fully removed stage I tumor, careful monitoring with exams, imaging, and blood markers may replace immediate chemotherapy, reserving treatment for the rare recurrence.
Tumor-marker follow-up
Blood tests such as LDH (and beta-hCG when present) are tracked to confirm response and to catch any recurrence early.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they can no longer divide and survive, while normal cells are better at repairing themselves. Dysgerminoma is one of the most radiation-sensitive of all cancers, so it once melted away with low doses of radiation. Today, chemotherapy has taken over because it cures the disease just as reliably while sparing the ovaries and preserving fertility — important for the young women this cancer usually affects. When radiation is used, it is given as short, painless daily sessions and leaves no radioactivity in your body, so you remain safe to be around family and children.
The main ways radiation is delivered for dysgerminoma:
Surgery
Removing the involved ovary and tube provides the diagnosis, removes the bulk of the tumor, and is often curative on its own for early disease.
Radiation (now rarely used)
Dysgerminoma is extremely radiosensitive, and radiation was once a mainstay. Today chemotherapy has largely replaced it because chemo cures the disease while better protecting fertility, so radiation is reserved for unusual situations where chemotherapy cannot be used.
Palliative radiation
Because the tumor melts away with even modest doses, a short course of radiation can quickly relieve symptoms in the rare resistant or recurrent case.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Cutting back treatment without losing cures: Studies of fertility-sparing surgery and active surveillance for early dysgerminoma show that many young women can avoid chemotherapy entirely, with treatment held in reserve for the uncommon recurrence and cure rates remaining near-universal.[1]
Gynecologic and pediatric germ-cell tumor studies (2020–2025)
Trimming chemotherapy toxicity: Research into shorter or modified platinum-based regimens aims to keep the very high cure rates while reducing long-term side effects such as hearing loss, nerve damage, and effects on future fertility.[2]
Cooperative-group germ-cell trials (2021–2025)
Protecting fertility and long-term health: Long-term follow-up confirms that most survivors who had fertility-sparing surgery can later conceive, supporting ovary-preserving approaches as the standard for young patients.[3]
Survivorship and fertility outcome studies (2020–2024)
Common questions
Can I still have children after treatment? Usually yes. For most young women, surgeons remove only the affected ovary and fallopian tube and leave the uterus and other ovary in place. Most survivors who had this fertility-sparing surgery are later able to conceive. Your team will tailor the plan to your situation.
Is dysgerminoma really curable even if it has spread? Yes. Dysgerminoma is one of the most curable cancers known. It responds so well to chemotherapy that even when it has spread, the large majority of patients are cured. Stage mainly affects how much treatment you need, not whether cure is possible.
Why do I need blood tests during follow-up? Many dysgerminomas raise markers like LDH (and sometimes beta-hCG). Tracking these in the blood helps confirm that treatment is working and can flag a recurrence early, when it is easiest to treat.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- Gynecologic and pediatric germ-cell tumor studies (2020–2025) (no indexed identifier — see your care team) ↩
- Cooperative-group germ-cell trials (2021–2025) (no indexed identifier — see your care team) ↩
- Survivorship and fertility outcome studies (2020–2024) (no indexed identifier — see your care team) ↩